Isotretinoin is an oral vitamin-A-like drug reserved for severe recalcitrant nodular acne that has not improved with standard therapy including systemic antibiotics. It can clear deep, stubborn nodules, but use requires strict pregnancy prevention, close monitoring for side effects, and monthly follow-up. This guide explains who qualifies, what side effects to expect, which warning signs need fast care, and what follow-up involves. It helps readers with severe acne and parents weigh whether to ask a dermatologist about this option.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Who is eligible for treatment?
- What common side effects should you expect?
- Which serious risks need fast action?
- What does follow-up and a typical course involve?
Who is eligible for treatment?
The National Library of Medicine DailyMed FDA label limits isotretinoin to nonpregnant patients age 12 and older with severe recalcitrant nodular acne, as described in the DailyMed FDA label. That means multiple 5-mm or larger inflammatory nodules that did not respond to conventional therapy. Conventional therapy includes systemic antibiotics unless they are unsuitable.
In the United States, prescribers, patients, and pharmacies must register in the FDA iPLEDGE safety program. The prescriber must confirm each prescription, and each prescription covers no more than a 30-day supply. Readers can use this quick check before a visit:.
- age 12 or older and not pregnant
- many large, inflamed nodules rather than mild blackheads or small pimples
- prior systemic antibiotics tried without lasting clearance, or a clear reason they cannot be used
- willing to follow monthly visits, lab tests, and birth-control rules when relevant
What common side effects should you expect?
Most patients develop vitamin-A-like dryness of lips, skin, nose, and eyes. Cheilitis, or cracked and sore lips, is especially common. Symptoms are often dose-related and usually reverse after stopping.
Guidelines advise starting moisturizer and lip balm at treatment onset. Use fragrance-free lip balm often, gentle cleanser, plain moisturizer, saline nasal gel if the nose feels dry, and artificial tears if eyes feel gritty. Tell the prescriber if dryness cracks, bleeds, or limits daily comfort.
Which serious risks need fast action?
Isotretinoin causes life-threatening birth defects and must not be used in pregnancy. Patients who can become pregnant need negative tests before and monthly during treatment, plus two contraceptives together from one month before through one month after treatment, according to FDA iPLEDGE materials. The drug can raise triglycerides and liver enzymes and can cause increased pressure around the brain, especially with tetracycline antibiotics, as warned in the DailyMed warnings. Do not take tetracyclines during isotretinoin treatment.
Stop the drug and seek care for severe headache, vision changes, nausea with vomiting, severe belly pain, yellowing skin, or very dark urine. The FDA label also warns of depression, psychosis, and suicide attempts. Patients and families should watch mood, sleep, behavior, withdrawal, aggression, and suicidal thoughts. Contact the prescriber promptly if these occur, and seek urgent help for any plan or attempt.
What does follow-up and a typical course involve?
Follow-up means monthly visits, with pregnancy testing when applicable. Care includes baseline plus repeat fasting lipids and liver tests, although exact timing varies because serious lab problems are uncommon. Patients must not donate blood during treatment and for one month after, and must not share leftover capsules.
A typical course starts near 0.5 mg per kg per day, then rises toward 1 mg per kg per day as tolerated. Treatment often lasts 16 to 24 weeks, until about 120 to 150 mg per kg total or about four weeks with no new lesions. Do not save or share extra capsules after the course ends.
You Might Also Like
- Pretreatment Pregnancy Testing Under iPLEDGE in 2026: What Changed, What Did Not, and What Comes Next for Parents of Teens With Severe Acne
- Pretreatment Pregnancy Testing Under iPLEDGE in 2026: Pharmacy and Prescriber Questions for Parents of Teens With Severe Acne
- Planned Home Pregnancy Testing Under the 2026 iPLEDGE Changes: What Changed, What Did Not, and What Comes Next for Parents of Teens With Severe Acne